We are live on
!
Find out more
M&G plc Portfolio holdings
AUM
$20.1B
Turnover
14.5%
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
(-0.55%)
Cap. Flow
-$6.32M
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43
Avg Time Held Equity + Options
1.3
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$811M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Intuit
INTU
|
+$152M |
| 4 |
Broadcom
AVGO
|
+$130M |
| 5 |
The Magnum Ice Cream Company N.V.
MICC
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$190M |
| 2 |
Elevance Health
ELV
|
+$109M |
| 3 |
CME Group
CME
|
+$92.3M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$79.9M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$67.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Healthcare | 16.38% |
| 3 | Consumer Discretionary | 15.42% |
| 4 | Financials | 11.36% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Qfin Holdings
QFIN
$708M
| $9.22M | 0.05% |
709,248
+7,608
| +1% | +$117K |
2025 Q4
1 quarter
|
|
202
Tesla
TSLA
$1.43T
| $9.16M | 0.05% |
24,625
+2,040
| +9% | +$840K |
2024 Q1
8 quarters
|
|
203
Boston Scientific
BSX
$64B
| $9.02M | 0.05% |
143,246
+1,266
| +0.9% | +$101K |
2024 Q3
6 quarters
|
|
204
Amkor Technology
AMKR
$10.9B
| $9.01M | 0.05% |
200,182
-105,720
| -35% | -$5.06M |
2024 Q1
8 quarters
|
|
205
Fermi Inc
FRMI
$2.18B
| $8.83M | 0.05% |
1,471,157
-334,258
| -19% | -$2.93M |
2025 Q4
1 quarter
|
|
206
Netflix
NFLX
$302B
| $8.71M | 0.05% |
90,725
+3,481
| +4% | +$307K |
2024 Q1
8 quarters
|
|
207
Owens Corning
OC
$8.99B
| $8.64M | 0.04% |
80,009
+21,096
| +36% | +$2.51M |
2024 Q1
8 quarters
|
|
208
Aptiv
APTV
$9.38B
| $8.54M | 0.04% |
123,820
| – | – |
2024 Q1
8 quarters
|
|
209
Smithfield Foods
SFD
$7.28B
| $8.53M | 0.04% |
304,608
+106,785
| +54% | +$2.57M |
2025 Q4
1 quarter
|
|
210
Best Buy
BBY
$19.8B
| $8.48M | 0.04% |
132,479
+13,725
| +12% | +$901K |
2024 Q1
8 quarters
|
|
211
Lithium Argentina AG
LAR
$783M
| $8.46M | 0.04% |
1,208,661
-192,558
| -14% | -$1.38M |
2024 Q1
8 quarters
|
|
212
Eagle Materials
EXP
$5.23B
| $8.42M | 0.04% |
44,555
+4,073
| +10% | +$867K |
2024 Q1
8 quarters
|
|
213
ServiceNow
NOW
$154B
| $8.17M | 0.04% |
77,765
-49,700
| -39% | -$5.85M |
2024 Q1
8 quarters
|
|
214
Zscaler
ZS
$35.9B
| $7.9M | 0.04% |
56,413
+14,308
| +34% | +$2.54M |
2025 Q3
2 quarters
|
|
215
Oracle
ORCL
$408B
| $7.66M | 0.04% |
52,078
-172,917
| -77% | -$28.1M |
2024 Q1
8 quarters
|
|
216
AMERISAFE
AMSF
$464M
| $7.45M | 0.04% |
225,786
-45,585
| -17% | -$1.64M |
2024 Q1
8 quarters
|
|
217
ExxonMobil
XOM
$718B
| $7.44M | 0.04% |
43,739
-4,706
| -10% | -$687K |
2024 Q1
8 quarters
|
|
218
Tractor Supply
TSCO
$17.4B
| $7.43M | 0.04% |
165,064
+54,963
| +50% | +$2.8M |
2024 Q1
8 quarters
|
|
219
KKR & Co
KKR
$78.7B
| $7.35M | 0.04% |
79,000
+18,000
| +30% | +$1.9M |
2024 Q4
5 quarters
|
|
220
Revolution Medicines
RVMD
$40.6B
| $7.25M | 0.04% |
74,733
-14,219
| -16% | -$1.44M |
2025 Q4
1 quarter
|
|
221
Blackstone Secured Lending
BXSL
$5.64B
| $7.2M | 0.04% |
300,000
| – | – |
2025 Q3
2 quarters
|
|
222
Eli Lilly
LLY
$1.12T
| $7.17M | 0.04% |
7,792
| – | – |
2024 Q1
8 quarters
|
|
223
General Motors
GM
$73.4B
| $7.14M | 0.04% |
95,239
-37,891
| -28% | -$3.01M |
2024 Q1
8 quarters
|
|
224
Doximity
DOCS
$5.61B
| $7.08M | 0.04% |
307,950
+5,998
| +2% | +$187K |
2025 Q4
1 quarter
|
|
225
Burford Capital
BUR
$722M
| $7.05M | 0.04% |
1,653,449
+468,200
| +40% | +$4.1M |
2024 Q1
8 quarters
|
|
Similar funds
SA
BBA
M&G plc's Q1 2026 Portfolio in Review
As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
- M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
- M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
- M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
- M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
- M&G plc opened 51 new positions and closed 43 in Q1 2026.
- M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.
Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.